Brief: Inmune Bio Closes nearly $19M At-Market Registered Direct Offering Under Nasdaq Rules
30/06/2025 21:13
June 30 (Reuters) - INmune Bio Inc INMB.O: INMUNE BIO, INC. ANNOUNCES CLOSING OF APPROXIMATELY $19 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX2hjBBp Further company coverage: INMB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview